Physician
Cardiology
Dr. Scott R. Spielman, MD
|
|
Give Review
Scott Spielman works in the field of Cardiology. He studied medicine at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is one of the top medical schools in the US. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Dr. Scott R. Spielman is also published. He has 62 publications published. The lastest publication: "The origin of ventricular arrhythmias 24 hours following experimental anterior septal coronary artery occlusion.' Scott R. Spielman, MD is registered with Medicare.
Publications
- Angiographic significance of a discordant ST-segment elevation of > or =5 millimeters in patients with ventricular-paced rhythm and acute myocardial infarction.
- Evolving indications for permanent pacemakers.
- Angina caused by systolic compression of the left coronary artery as a result of pseudoaneurysm of the mitral-aortic intervalvular fibrosa.
- Activation mapping in ventricular tachycardia: role of the epicardium.
- Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
- Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
- The electrophysiologic properties of esmolol, a short acting beta-blocker.
- Determinants of hospital cost and length of stay for patients undergoing electrophysiologic testing.
- Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone.
- Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained v...
- Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients.
- Proarrhythmic responses during electrophysiologic testing.
- Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
- Influence of left ventricular dysfunction on flecainide therapy.
- Plasma norepinephrine in exercise-induced ventricular tachycardia.
- Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
- Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
- Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
- Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy.
- Electrophysiology of esmolol.
- The clinical electrophysiology of intravenous indecainide.
- Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
- Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
- Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular function.
- Pacemakers: normal function.
- Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia.
- Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies.
- Improved method for evaluating ventriculoatrial conduction before implantation of atrial-sensing dual chamber pacemakers.
- Ventricular activation in normal sinus rhythm: abnormalities with recurrent sustained tachycardia and a history of myocardial infarction.
- Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.
- Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
- The selection of antiarrhythmic regimens by electrophysiologic studies: techniques and results.
- Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
- Early experience with an implantable cardioverter.
- Selection of patients with recurrence of ventricular tachyarrhythmias for electrical studies.
- Ventricular arrhythmias: use of electrophysiologic studies.
- Predictors of the success or failure of medical therapy in patients with chronic recurrent sustained ventricular tachycardia: a discriminant analysis.
- Relation between late potentials on the body surface and directly recorded fragmented electrograms in patients with ventricular tachycardia.
- Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action.
- Role of programmed stimulation in assessing vulnerability to ventricular arrhythmias.
- Mechanisms in the genesis of recurrent ventricular tachyarrhythmias as revealed by clinical electrophysiologic studies.
- Role of catheter mapping in the preoperative evaluation of ventricular tachycardia.
- One-to-two atrioventricular conduction in Wolff-Parkinson-White syndrome: a mechanism of initiating supraventricular tachycardia.
- Sustained ventricular tachycardia: role of the 12-lead electrocardiogram in localizing site of origin.
- Anatomic and electrophysiologic correlates of ventricular tachycardia requiring left ventricular stimulation.
- Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities.
- Human ventricular refractoriness: effects of increasing current.
- Electrophysiologic and hemodynamic studies in patients resuscitated from cardiac arrest.
- Large dose procainamide therapy for ventricular tachyarrhythmia.
- Repetitive responses to ventricular extrastimuli: incidence, mechanism, and significance.
- Strength-interval relation in the human ventricle: effect of procainamide.
- Incidence and clinical significance of induced ventricular tachycardia.
- Comparison of endocardial catheter mapping with intraoperative mapping of ventricular tachycardia.
- Mechanism of ventricular fibrillation in man. Observations based on electrode catheter recordings.
- Electrophysiologic study of the left ventricle: indications and safety.
- Recurrent sustained ventricular tachycardia. 4. Pleomorphism.
- Ventricular fibrillation during programmed ventricular stimulation: incidence and clinical implications.
- Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
- Sustained ventricular tachycardia: evidence for protected localized reentry.
- The limitations of epicardial mapping as a guide to the surgical therapy of ventricular tachycardia.
- The origin of ventricular arrhythmias 24 hours following experimental anterior septal coronary artery occlusion.
Schools
Columbia University College Of Physicians and Surgeons
Penn Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Pennsylvania Health System -
Columbia University College of Physicians & Surgeons
Hospital
-
Abington Hospital - Jefferson Health -
Einstein Medical Center Philadelphia -
Holy Redeemer Hospital
Drug Facts
| NPI NUMBER | 1932102878 | |
| NPPES Provider LastName | SPIELMAN | |
| NPPES Provider FirstName | SCOTT | |
| NPPES Provider ZIPCode | 190463724 | |
| NPPES Provider State | PA | |
| Specialty Description | Cardiac Electrophysiology | |
| Total Claim Count | 879.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932102878 |
| Last Name Of The Provider | SPIELMAN |
| First Name Of The Provider | SCOTT |
| View All |
Similar Doctors
|
Dr. David J. Waldstein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles E. Bemis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John H. Wertheimer, MD |
|
Dr. Roger A. Marinchak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William S. Haaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter B. Frechie, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven J. Mattleman, MD
This Doctor is OpenDoctor Recommended.
|